Dr. Daniela Araújo became a biomedical engineer at the University of Minho, which included a thesis developed at the Centre for Biological Engineering (CEB), entitled "Antisense Therapy: a new strategy to control Candida infections". During this period, she had the opportunity to develop skills in the field of antisense therapy and virulence factors of Candida species. In 2021, she completed her Ph.D. in Chemical and Biological Engineering at CEB-UM and the Department of Physics, Chemistry and Pharmacy (FKF) at the University of Southern Denmark, focusing on "Application of antisense oligonucleotides to prevent Candida albicans infections". The main objective was to develop a novel therapeutic approach based on antisense therapy to track C. albicans filamentation using established and new-generation NAMs. Her research interests mainly focus on antisense oligonucleotides, bacterial infections, Candida infections, and novel therapies.
Dr. Daniela Araújo became a biomedical engineer at the University of Minho, which included a thesis developed at the Centre for Biological Engineering (CEB), entitled "Antisense Therapy: a new strategy to control Candida infections". During this period, she had the opportunity to develop skills in the field of antisense therapy and virulence factors of Candida species. In 2021, she completed her Ph.D. in Chemical and Biological Engineering at CEB-UM and the Department of Physics, Chemistry and Pharmacy (FKF) at the University of Southern Denmark, focusing on "Application of antisense oligonucleotides to prevent Candida albicans infections". The main objective was to develop a novel therapeutic approach based on antisense therapy to track C. albicans filamentation using established and new-generation NAMs. Her research interests mainly focus on antisense oligonucleotides, bacterial infections, Candida infections, and novel therapies.